Loading…
Loading…
CMS Energy (CMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
California Public Employees Retirement System lowered its position in CMS Energy Corporation (NYSE: CMS) by 16.9% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 633,281 shares of the utilities provider's stock after selling 128,881 shares during the quarter. California Public Employees Retirement
JACKSON, Mich., July 20, 2026 /PRNewswire/ -- The Board of Directors of CMS Energy has declared a quarterly dividend on the company's common stock.
CMS Energy (CMS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
CMS Energy (CMS) is reaffirmed as a Buy, supported by a $24 billion five-year capex plan driving robust rate base and EPS growth. CMS targets 6–8% annual adjusted EPS growth, with consensus estimates at the high end, and maintains a stable BBB credit rating. Shares trade at a modest 3% discount to fair value, with potential for 9%+ annual total returns through 2031, underpinned by disciplined capital deployment.
SHANGHAI, July 12, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 03696.HK), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), and China Medical System Holdings Limited ("CMS", 867.HK/8A8.SG), an open-platform innovative company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, today announced an additional AI‑empowered drug discovery collaboration targeting a mass-market indication in central nervous system with an innovative mechanism of action (MoA) identified by PandaOmics. According to the collaboration agreement, the two parties will jointly advance the co-development of the R&D program by combining Insilico Medicine's validated AI platform and AI-enabled innovative drug discovery and development capabilities with CMS's experienced R&D team and deep therapeutic expertise.
Skyrocketing demand from artificial intelligence data centers is exacerbating shortages of critical grid equipment like transformers across the U.S., driving up costs, stretching out wait times and spurring utilities and developers to lock in orders far in advance.
JACKSON, Mich., July 7, 2026 /PRNewswire/ -- CMS Energy announced today it will provide 2026 second quarter results along with a business and financial outlook at 10:00 a.m.
Full call transcripts — prepared remarks + analyst Q&A — with speaker-by-speaker formatting and one-click switching across every quarter on file.
Click below to see what's inside, then upgrade to read every transcript for CMS and 80,000+ other tickers.
Transcripts source: company-published earnings calls. Speaker attribution and formatting are processed in-app.